Summit Therapeutics SMMT Increase (Decrease) in Prepaid Expense and Other Assets
Increase (Decrease) in Prepaid Expense and Other Assets at other companies
Other financials
Where this comes from
Reported directly by Summit Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.
The official record: Summit Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Summit Therapeutics's increase (decrease) in prepaid expense and other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Summit Therapeutics's increase (decrease) in prepaid expense and other assets?
- Summit Therapeutics (SMMT) reported increase (decrease) in prepaid expense and other assets of $11.01M in Q1 2026.
- How has Summit Therapeutics's increase (decrease) in prepaid expense and other assets changed year-over-year?
- Summit Therapeutics's increase (decrease) in prepaid expense and other assets increased by 695.4% year-over-year, from -$1.85M to $11.01M.
- What is the long-term trend for Summit Therapeutics's increase (decrease) in prepaid expense and other assets?
- Over 3 years (2022 to 2025), Summit Therapeutics's increase (decrease) in prepaid expense and other assets has grown at a -1.6% compound annual growth rate (CAGR), from -$5.11M to -$4.87M.